U.S. market Closed. Opens in 17 hours 15 minutes

PRTG | Portage Biotech Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-311999-03-311998-03-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A41.92K241.38K644.75K1.59M311.46KN/A10.39K41.92K76.14K21.01KN/AN/A
Cost of Revenue54.00K1.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A956.97KN/AN/A
Gross Profit-54.00K-1.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A98.41KN/AN/AN/A41.92K241.38KN/A1.59M311.46KN/AN/A41.92K76.14K-935.96KN/AN/A
Operating Expenses18.20M16.58M15.59M12.44M5.98M2.76M2.23M35.49M9.19M4.32M2.79M1.24M1.69M3.49M3.28M536.14K728.74K674.53K2.20M4.36M1.07M226.99K711.16K440.32K21.30K316.48K389.60K
Selling, General & Admin5.66M8.36M8.82M5.13M1.87M1.87M1.55M2.56M4.52M1.30M1.67M1.73M1.60M2.49M2.56M631.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development12.54M8.21M6.77M7.31M4.11M762.00K561.00K32.45M4.58M2.93M1.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/A-1.26MN/A134.00K116.00K484.52K95.34K91.69K-13.19K-494.33K86.61K996.88K718.14K-94.87K728.74K674.53K2.20M4.36M1.07M226.99K711.16K440.32K21.30K316.48K389.60K
Operating Income-18.25M-16.57M-15.59M-12.44M-5.98M-2.76M-2.23M-35.49M-9.19M-4.32M-2.79M-1.24M-1.69M-3.49M-3.28M-494.21K-487.35K-29.78K-607.00K-4.05M-1.07M-216.59K-669.24K-364.18K-957.26K-316.48K-389.60K
Other Expenses / Income-67.44M-106.15M771.00K-2.45M894.00K-853.00K125.97M34.85M-7.38K-24.16K-3.84M-211.44K-787.23K-397.85K-246.01K-49.90K-137.80K459.92K-5.25M330.13K35.62K9.11K-161.12K-729.03KN/AN/AN/A
Before Tax Income-85.70M-122.52M-14.82M-14.89M-5.08M-3.59M123.74M-641.27K-9.20M-4.34M-6.63M-1.45MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-10.55M-17.86M4.35M2.30M2.17M-217.00K-126.00MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-75.34M-104.61M-19.17M-17.19M-7.25M-2.63M249.74M16.30M-5.71M-3.12M-6.30M-1.45M-2.48M-3.84M-3.85M-545.98K-555.52K-142.20K-4.10M-4.18M-1.04M-217.58K-835.74K-1.09M-957.26K-316.50K-396.64K
Interest Expenses32.00K9.00K43.00K177.00K557.00K88.00K32.00K552.42K7.38K20.04K3.35K2.18K1.75K4.21K677.91K1.87K1.58KN/A3.46K3.24K2.83KN/A1.08K6.15KN/AN/AN/A
Basic Shares Outstanding20.34M16.12M13.06M11.73M10.95M4.82M2.68M2.54M2.40M1.93M1.62M817.59K786.81K784.70K429.63K301.71K287.22K272.81K157.81K117.59K36.66K10.32K7.07K6.45K5.79K3.05K1.58K
Diluted Shares Outstanding20.34M16.12M13.06M11.73M10.95M4.82M2.70M2.72M2.40M1.93M1.62M817.59K786.81K784.70K429.63K301.71K287.22K272.81K157.81K117.59K36.66K10.32K7.07K6.45K5.79K3.05K1.58K
EBITDA-18.20M-16.62M-15.65M-14.19M-5.95M-2.81M123.77M-49.95M-9.19M-4.32M-2.79M-1.23M-897.59K-3.09M-3.03M-542.51K-553.15K-142.20K-4.10M-4.18M-1.11M-217.58K-811.62K-1.06M-942.48K-304.29K-378.12K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,294.04%-229.16%-22.06%-257.36%-1,341.01%0.00%-2,093.35%-1,936.09%-1,393.82%-4,484.96%0.00%0.00%
EBIT-85.86M-122.46M-14.77M-14.71M-4.53M-2.76M123.77M16.85M-5.70M-3.10M-6.30M-1.44M-2.47M-3.83M-3.17M-544.11K-553.94K-142.20K-4.10M-4.18M-1.04M-217.58K-834.66K-1.08M-957.26K-316.50K-396.64K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,297.87%-229.49%-22.06%-257.36%-1,341.01%0.00%-2,093.35%-1,991.05%-1,422.92%-4,555.29%0.00%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-311999-03-311998-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙